자살의 생물학적 기전

키워드

참고문헌 (132)

1. Turecki G, "The molecular bases of the suicidal brain", Nat Rev Neurosci, 15, pp.802~816 (2014)
2. Turecki G, "Suicide and suicidal behaviour", Lancet, 387, pp.1227~1239 (2016)
3. Turecki G, "Preventing suicide: where are we?", Lancet Psychiatry, 3, pp.597~598 (2016)
4. O’Connor RC, "The psychology of suicidal behaviour", Lancet Psychiatry, 1, pp.73~85 (2014)
5. Mann JJ, "Neurobiology of suicidal behaviour", Nat Rev Neurosci, 4, pp.819~828 (2003)
6. Moscicki EK, "Gender differences in completed and attempted suicides", Ann Epidemiol, 4, pp.152~158 (1994)
7. Van Orden KA, "The interpersonal theory of suicide", Psychol Rev, 117, pp.575~600 (2010)
8. Brent DA, "Risk factors for adolescent suicide and suicidal behavior: mental and substance abuse disorders, family environmental factors, and life stress", Suicide Life Threat Behav, 25 Suppl, pp.52~63 (1995)
9. Kim CD, "Familial aggregation of suicidal behavior:a family study of male suicide completers from the general population", Am J Psychiatry, 162, pp.1017~1019 (2005)
10. McGirr A, "Familial aggregation of suicide explained by cluster B traits: a three-group family study of suicide controlling for major depressive disorder", Am J Psychiatry, 166, pp.1124~1134 (2009)
11. Tidemalm D, "Familial clustering of suicide risk: a total population study of 11.4 million individuals", Psychol Med, 41, pp.2527~2534 (2011)
12. von Borczyskowski A, "Familial factors and suicide: an adoption study in a Swedish National Cohort", Psychol Med, 41, pp.749~758 (2011)
13. Menke A, "Genome-wide association study of antidepressant treatment-emergent suicidal ideation", Neuropsychopharmacology, 37, pp.797~807 (2012)
14. Perlis RH, "Genome-wide association study of suicide attempts in mood disorder patients", Am J Psychiatry, 167, pp.1499~1507 (2010)
15. Galfalvy H, "A pilot genome wide association and gene expression array study of suicide with and without major depression", World J Biol Psychiatry, 14, pp.574~582 (2013)
16. Perroud N, "Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project", Pharmacogenomics J, 12, pp.68~77 (2012)
17. Willour VL, "A genome-wide association study of attempted suicide", Mol Psychiatry, 17, pp.433~444 (2012)
18. Perlis RH, "Copy number variation in subjects with major depressive disorder who attempted suicide", PLoS One, 7, pp.e46315~ (2012)
19. Gilbert R, "Burden and consequences of child maltreatment in high-income countries", Lancet, 373, pp.68~81 (2009)
20. Fanous AH, "The prediction of thoughts of death or self-harm in a population-based sample of female twins", Psychol Med, 34, pp.301~312 (2004)
21. Brezo J, "Natural history of suicidal behaviors in a population-based sample of young adults", Psychol Med, 37, pp.1563~1574 (2007)
22. Lopez-Castroman J, "Early childhood sexual abuse increases suicidal intent", World Psychiatry, 12, pp.149~154 (2013)
23. Brezo J, "Predicting suicide attempts in young adults with histories of childhood abuse", Br J Psychiatry, 193, pp.134~139 (2008)
24. Fergusson DM, "Risk factors and life processes associated with the onset of suicidal behaviour during adolescence and early adulthood", Psychol Med, 30, pp.23~39 (2000)
25. Angst J, "The Zurich Study: XV. Suicide attempts in a cohort from age 20 to 30", Eur Arch Psychiatry Clin Neurosci, 242, pp.135~141 (1992)
26. Hertzman C, "Putting the concept of biological embedding in historical perspective", Proc Natl Acad Sci U S A, 2, pp.17160~17167 (2012)
27. Heim C, "Neurobiological and psychiatric consequences of child abuse and neglect", Dev Psychobiol, 52, pp.671~690 (2010)
28. McGowan PO, "Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse", Nat Neurosci, 12, pp.342~348 (2009)
29. Binder EB, "Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults", JAMA, 299, pp.1291~1305 (2008)
30. Supriyanto I, "Association of FKBP5 gene haplotypes with completed suicide in the Japanese population", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.252~256 (2011)
31. Labonte B, "Genome-wide methylation changes in the brains of suicide completers", Am J Psychiatry, 170, pp.511~520 (2013)
32. Weder N, "Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry", J Am Acad Child Adolesc Psychiatry, 53, pp.417.e5~424.e5 (2014)
33. Roth TL, "Lasting epigenetic influence of early-life adversity on the BDNF gene", Biol Psychiatry, 65, pp.760~769 (2009)
34. Roth TL, "Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder", J Psychiatr Res, 45, pp.919~926 (2011)
35. Dwivedi Y, "Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects", Arch Gen Psychiatry, 60, pp.804~815 (2003)
36. Pandey GN, "Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims", Int J Neuropsychopharmacol, 11, pp.1047~1061 (2008)
37. Ernst C, "Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers", Arch Gen Psychiatry, 66, pp.22~32 (2009)
38. Keller S, "Increased BDNF promoter methylation in the Wernicke area of suicide subjects", Arch Gen Psychiatry, 67, pp.258~267 (2010)
39. Banerjee R, "Decreased mRNA and Protein Expression of BDNF, NGF, and their Receptors in the Hippocampus from Suicide: An Analysis in Human Postmortem Brain", Clin Med Insights Pathol, 6, pp.1~11 (2013)
40. Fuchikami M, "DNA methylation profiles of the brain-derived neurotrophic factor(BDNF) gene as a potent diagnostic biomarker in major depression", PLoS One, 6, pp.e23881~ (2011)
41. Kim JM, "Association of BDNF promoter methylation and genotype with suicidal ideation in elderly Koreans", Am J Geriatr Psychiatry, 22, pp.989~996 (2014)
42. Zhang X, "Genome-wide high-resolution mapping and functional analysis of DNA methylation in arabidopsis", Cell, 126, pp.1189~1201 (2006)
43. Ziller MJ, "Charting a dynamic DNA methylation landscape of the human genome", Nature, 500, pp.477~481 (2013)
44. Schroeder M, "The epigenetic code in depression: implications for treatment", Clinical Pharmacology & Therapeutics, 91, pp.310~314 (2012)
45. Turecki G, "Early life adversity, genomic plasticity, and psychopathology", Lancet Psychiatry, 1, pp.461~466 (2014)
46. Brent DA, "Suicidal behavior runs in families. A controlled family study of adolescent suicide victims", Arch Gen Psychiatry, 53, pp.1145~1152 (1996)
47. Courtet P, "The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies?", Transl Psychiatry, 1 (2011)
48. Brezo J, "Childhood trajectories of anxiousness and disruptiveness as predictors of suicide attempts", Arch Pediatr Adolesc Med, 162, pp.1015~1021 (2008)
49. Dumais A, "Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men", Am J Psychiatry, 162, pp.2116~2124 (2005)
50. Arsenault-Lapierre G, "Psychiatric diagnoses in 3275 suicides: a meta-analysis", BMC Psychiatry, 4, pp.37~ (2004)
51. Rucker JJ, "Genome-wide association analysis of copy number variation in recurrent depressive disorder", Mol Psychiatry, 18, pp.183~189 (2013)
52. Kim C, "Patterns of co-morbidity in male suicide completers", Psychol Med, 33, pp.1299~1309 (2003)
53. Seguin M, "Life trajectories and burden of adversity: mapping the developmental profiles of suicide mortality", Psychol Med, 37, pp.1575~1583 (2007)
54. Chachamovich E, "Levels of aggressiveness are higher among alcohol-related suicides: results from a psychological autopsy study", Alcohol, 46, pp.529~536 (2012)
55. Coccaro EF, "Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior", Arch Gen Psychiatry, 46, pp.587~599 (1989)
56. Freemantle E, "Analysis of oxysterols and cholesterol in prefrontal cortex of suicides", Int J Neuropsychopharmacol, 16, pp.1241~1249 (2013)
57. Lalovic A, "Cholesterol content in brains of suicide completers", Int J Neuropsychopharmacol, 10, pp.159~166 (2007)
58. Ernst C, "Suicide neurobiology", Prog Neurobiol, 89, pp.315~333 (2009)
59. Qin P, "Suicide risk in relation to family history of completed suicide and psychiatric disorders: a nested case-control study based on longitudinal registers", Lancet, 360, pp.1126~1130 (2002)
60. Asberg M, "Serotonin depression”--a biochemical subgroup within the affective disorders?", Science, 191, pp.478~480 (1976)
61. Stanley M, "Tritiated imipramine binding sites are decreased in the frontal cortex of suicides", Science, 216, pp.1337~1339 (1982)
62. Stanley M, "Increased serotonin-2 binding sites in frontal cortex of suicide victims", Lancet, 1, pp.214~216 (1983)
63. Mann JJ, "The serotonergic system in mood disorders and suicidal behaviour", Philos Trans R Soc Lond B Biol Sci, 368, pp.20120537~ (2013)
64. WAY100635 positron emission tomography study, "Biol Psychiatry", 2006, 106~113
65. Arango V, "Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims", Neuropsychopharmacology, 25, pp.892~903 (2001)
66. Miller JM, "Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder", Biol Psychiatry, 74, pp.287~295 (2013)
67. Yanowitch R, "The neurochemistry of human aggression", Adv Genet, 75, pp.151~169 (2011)
68. Brezo J, "Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders:a 22-year longitudinal gene-environment study", Mol Psychiatry, 15, pp.831~843 (2010)
69. Smith KA, "Relapse of depression after rapid depletion of tryptophan", Lancet, 349, pp.915~919 (1997)
70. Benkelfat C, "Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders", Arch Gen Psychiatry, 51, pp.687~697 (1994)
71. Arango V, "Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results", Biol Psychiatry, 39, pp.112~120 (1996)
72. Galfalvy H, "Lower CSF MHPG predicts short-term risk for suicide attempt", Int J Neuropsychopharmacol, 12, pp.1327~1335 (2009)
73. van Heeringen K, "The neurobiology of suicide", Lancet Psychiatry, 1, pp.63~72 (2014)
74. Choudary PV, "Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression", Proc Natl Acad Sci U S A, 102, pp.15653~15658 (2005)
75. Sequeira A, "Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression", PLoS One, 4, pp.e6585~ (2009)
76. Larkin GL, "A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department", Int J Neuropsychopharmacol, 14, pp.1127~1131 (2011)
77. Price RB, "Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression", Depress Anxiety, 31, pp.335~343 (2014)
78. Gilad GM, "Overview of the brain polyaminestress-response: regulation, development, and modulation by lithium and role in cell survival", Cell Mol Neurobiol, 23, pp.637~649 (2003)
79. Hayashi Y, "Polyamine levels in brain and plasma after acute restraint or water-immersion restraint stress in mice", Neurosci Lett, 355, pp.57~60 (2004)
80. Doyle KM, "Effect of Ltype calcium channel antagonists on spermine-induced CNS excitation in vivo", Neurosci Lett, 380, pp.247~251 (2005)
81. Sequeira A, "Implication of SSAT by gene expression and genetic variation in suicide and major depression", Arch Gen Psychiatry, 63, pp.35~48 (2006)
82. Fiori LM, "Global gene expression profiling of the polyamine system in suicide completers", Int J Neuropsychopharmacol, 14, pp.595~605 (2011)
83. Klempan TA, "Profiling brain expression of the spermidine", spermine N1-acetyltransferase 1(SAT1)gene in suicide, 2009, pp.150B, 934~943
84. Chen GG, "Evidence of altered polyamine concentrations in cerebral cortex of suicide completers", Neuropsychopharmacology, 35, pp.1477~1484 (2010)
85. Guipponi M, "Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior", Am J Med Genet B Neuropsychiatr Genet, 150, pp.799~807 (2009)
86. Le-Niculescu H, "Discovery and validation of blood biomarkers for suicidality", Mol Psychiatry, 18, pp.1249~1264 (2013)
87. Dahel KA, "Polyamine oxidase activity in sera of depressed and schizophrenic patients after ECT treatment", Neurochem Res, 26, pp.415~418 (2001)
88. Engelberg H, "Low serum cholesterol and suicide", Lancet, 339, pp.727~729 (1992)
89. Wu S, "Serum lipid levels and suicidality: a meta-analysis of 65 epidemiological studies", J Psychiatry Neurosci, 41, pp.56~69 (2016)
90. De Berardis D, "The Relationships between Cholesterol and Suicide: An Update", ISRN Psychiatry, 2012, pp.387901~ (2012)
91. Serafini G, "The role of inflammatory cytokines in suicidal behavior: a systematic review", Eur Neuropsychopharmacol, 23, pp.1672~1686 (2013)
92. Isung J, "Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters", Transl Psychiatry, 2, pp.e196~ (2012)
93. Erhardt S, "Connecting inflammation with glutamate agonism in suicidality", Neuropsychopharmacology, 38, pp.743~752 (2013)
94. Sublette ME, "Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder", Brain Behav Immun, 25, pp.1272~1278 (2011)
95. Carlborg A, "CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis", Psychiatry Res, 205, pp.165~167 (2013)
96. Bay-Richter C, "A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality", Brain Behav Immun, 43, pp.110~117 (2015)
97. Pandey GN, "Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims", J Psychiatr Res, 46, pp.57~63 (2012)
98. Tonelli LH, "Elevated cytokine expression in the orbitofrontal cortex of victims of suicide", Acta Psychiatr Scand, 117, pp.198~206 (2008)
99. Torres-Platas SG, "Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides", Brain Behav Immun, 42, pp.50~59 (2014)
100. Steiner J, "Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide", J Psychiatr Res, 42, pp.151~157 (2008)
101. Ehlert U, "Enduring psychobiological effects of childhood adversity", Psychoneuroendocrinology, 38, pp.1850~1857 (2013)
102. Danese A, "Elevated inflammation levels in depressed adults with a history of childhood maltreatment", Arch Gen Psychiatry, 65, pp.409~415 (2008)
103. Rajkowska G, "Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells", Biol Psychiatry, 48, pp.766~777 (2000)
104. Torres-Platas SG, "Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides", Neuropsychopharmacology, 36, pp.2650~2658 (2011)
105. Ernst C, "Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers", Biol Psychiatry, 70, pp.312~319 (2011)
106. Bernard R, "Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression", Mol Psychiatry, 16, pp.634~646 (2011)
107. Rose CR, "Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells", Nature, 426, pp.74~78 (2003)
108. Razzoli M, "A role for BDNF", TrkB signaling in behavioral and physiological consequences of social defeat stress, 2011, pp.10, 424~433
109. Roy A, "Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression", Biol Psychiatry, 32, pp.812~816 (1992)
110. Coryell W, "The dexamethasone suppression test and suicide prediction", Am J Psychiatry, 158, pp.748~753 (2001)
111. Pfeffer CR, "Suicidal behav ior and hypothalamic-pituitary-adrenocortical axis indices in child psychiatric inpatients", Biol Psychiatry, 29, pp.909~917 (1991)
112. Raadsheer FC, "Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression", Am J Psychiatry, 152, pp.1372~1376 (1995)
113. Raadsheer FC, "Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients", Neuroendocrinology, 60, pp.436~444 (1994)
114. Wang SS, "Gene expression analysis in the human hypothalamus in depression by laser microdissection and realtime PCR: the presence of multiple receptor imbalances", Mol Psychiatry, 13, pp.786~799 (2008)
115. Nemeroff CB, "Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients", Science, 226, pp.1342~1344 (1984)
116. Nemeroff CB, "Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims", Arch Gen Psychiatry, 45, pp.577~579 (1988)
117. Lopez JF, "Localization and quantification of proopiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims", Neuroendocrinology, 56, pp.491~501 (1992)
118. Dumser T, "Weight of adrenal glands may be increased in persons who commit suicide", Am J Forensic Med Pathol, 19, pp.72~76 (1998)
119. Szigethy E, "Adrenal weight and morphology in victims of completed suicide", Biol Psychiatry, 36, pp.374~380 (1994)
120. McGirr A, "Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide", J Psychiatry Neurosci, 35, pp.399~408 (2010)
121. Oquendo MA, "Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression", Arch Gen Psychiatry, 60, pp.14~22 (2003)
122. Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters, "Eur Neuropsychopharmacol", 2006, 220~223
123. van Heeringen K, "The functional neuroanatomy of mental pain in depression", Psychiatry Res, 181, pp.141~144 (2010)
124. Oquendo MA, "Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior", JAMA Psychiatry, 73, pp.1048~1055 (2016)
125. van Heeringen C, "Suicidal brains: a review of functional and structural brain studies in association with suicidal behaviour", Neurosci Biobehav Rev, 35, pp.688~698 (2011)
126. Tanaka SC, "Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops", Nat Neurosci, 7, pp.887~893 (2004)
127. Richard-Devantoy S, "A metaanalysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders", Psychol Med, 44, pp.1663~1673 (2014)
128. Jollant F, "Orbitofrontal cortex response to angry faces in men with histories of suicide attempts", Am J Psychiatry, 165, pp.740~748 (2008)
129. Pan L, "Preserved hippocampal function during learning in the context of risk in adolescent suicide attempt", Psychiatry Res, 211, pp.112~118 (2013)
130. Willeumier K, "Decreased cerebral blood flow in the limbic and prefrontal cortex using SPECT imaging in a cohort of completed suicides", Transl Psychiatry, 1, pp.e28~ (2011)
131. Jollant F, "Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior", Neuroimage, 51, pp.1275~1281 (2010)
132. Pan LA, "Dissociable patterns of neural activity during response inhibition in depressed adolescents with and without suicidal behavior", J Am Acad Child Adolesc Psychiatry, 50, pp.602~611 (2011)

관련 논문AI추천